Susquehanna International Group’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,660,900
| Closed | -$24.4M | – | 12671 |
|
|
2025
Q3 | $24.4M | Buy |
1,660,900
+1,041,300
| +168% | +$10.6M | ﹤0.01% | 1995 |
|
|
2025
Q2 | $6.08M | Buy |
619,600
+539,900
| +677% | +$4.47M | ﹤0.01% | 3619 |
|
|
2025
Q1 | $579K | Buy |
79,700
+30,100
| +61% | +$263K | ﹤0.01% | 8585 |
|
|
2024
Q4 | $388K | Sell |
49,600
-368,000
| -88% | -$3.03M | ﹤0.01% | 9278 |
|
|
2024
Q3 | $3.09M | Sell |
417,600
-18,300
| -4% | -$154K | ﹤0.01% | 4481 |
|
|
2024
Q2 | $3.49M | Sell |
435,900
-10,600
| -2% | -$94.7K | ﹤0.01% | 4038 |
|
|
2024
Q1 | $5.2M | Sell |
446,500
-28,100
| -6% | -$311K | ﹤0.01% | 3574 |
|
|
2023
Q4 | $5.3M | Buy |
474,600
+24,200
| +5% | +$222K | ﹤0.01% | 3612 |
|
|
2023
Q3 | $6.95M | Sell |
450,400
-48,000
| -10% | -$806K | ﹤0.01% | 3027 |
|
|
2023
Q2 | $9.44M | Buy |
498,400
+158,200
| +47% | +$2.78M | ﹤0.01% | 2570 |
|
|
2023
Q1 | $5.18M | Buy |
340,200
+293,300
| +625% | +$3.82M | ﹤0.01% | 3414 |
|
|
2022
Q4 | $597K | Sell |
46,900
-1,000
| -2% | -$9K | ﹤0.01% | 7392 |
|
|
2022
Q3 | $277K | Buy |
+47,900
| New | +$210K | ﹤0.01% | 9992 |
|
|
2021
Q3 | – | Sell |
-17,300
| Closed | -$324K | – | 12921 |
|
|
2021
Q2 | $324K | Sell |
17,300
-2,900
| -14% | -$64.7K | ﹤0.01% | 10601 |
|
|
2021
Q1 | $478K | Buy |
20,200
+3,800
| +23% | +$87.7K | ﹤0.01% | 9583 |
|
|
2020
Q4 | $400K | Buy |
+16,400
| New | +$419K | ﹤0.01% | 8731 |
|
Other funds holding ETNB
Susquehanna International Group's ETNB Position: Q4 2025 in Review
Susquehanna International Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 651,873 shares — an estimated $9.58M sold.
Susquehanna International Group first reported a position in ETNB in Q1 2021 and held it in 15 quarters. The position peaked at $9.81M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Susquehanna International Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 651,873 89bio shares in Q4 2025, an estimated $9.58M.
- Susquehanna International Group first reported a position in 89bio in Q1 2021 and held it in 15 quarters.
- Susquehanna International Group's 89bio position peaked at $9.81M in Q1 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.